Blood groups as biomarker to Optimize Odds of response to anti-PD-1 Drugs (BLOOD trial) Ghent University
Dampening of the immune response is coordinated by the expression of immune checkpoint receptors to
avoid autoimmunity and the deleterious effects of an excessive inflammatory response. It is well established that multiple
cell types within the tumor microenvironment hijack these checkpoint signaling pathways to restrain T cell activation and
as such an effective ...